Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xiaoman Liu, Siew-Kee Low & Alan V. Boddy. (2016) The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 12:8, pages 851-863.
Read now
Read now
Lynne
A. Fieber, Justin
B. Greer, Fujiang Guo, Douglas
L. Crawford & Kathleen
S. Rein. (2012) Gene expression profiling of human liver carcinoma (HepG2) cells exposed to the marine toxin okadaic acid. Toxicological & Environmental Chemistry 94:9, pages 1805-1821.
Read now
Read now
Articles from other publishers (33)
Qinglian Zhai, Maaike van der Lee, Teun van Gelder & Jesse J. Swen. (2022) Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity. Frontiers in Pharmacology 13.
Crossref
Crossref
Nichola Johnson, Sarah Maguire, Anna Morra, Pooja Middha Kapoor, Katarzyna Tomczyk, Michael E. Jones, Minouk J. Schoemaker, Clare Gilham, Manjeet K. Bolla, Qin Wang, Joe Dennis, Thomas U. Ahearn, Irene L. Andrulis, Hoda Anton-Culver, Natalia N. Antonenkova, Volker Arndt, Kristan J. Aronson, Annelie Augustinsson, Caroline Baynes, Laura E. Beane Freeman, Matthias W. Beckmann, Javier Benitez, Marina Bermisheva, Carl Blomqvist, Bram Boeckx, Natalia V. Bogdanova, Stig E. Bojesen, Hiltrud Brauch, Hermann Brenner, Barbara Burwinkel, Daniele Campa, Federico Canzian, Jose E. Castelao, Stephen J. Chanock, Georgia Chenevix-Trench, Christine L. Clarke, Don M. Conroy, Fergus J. Couch, Angela Cox, Simon S. Cross, Kamila Czene, Thilo Dörk, A. Heather Eliassen, Christoph Engel, D. Gareth Evans, Peter A. Fasching, Jonine Figueroa, Giuseppe Floris, Henrik Flyger, Manuela Gago-Dominguez, Susan M. Gapstur, Montserrat García-Closas, Mia M. Gaudet, Graham G. Giles, Mark S. Goldberg, Anna González-Neira, Pascal Guénel, Eric Hahnen, Christopher A. Haiman, Niclas Håkansson, Per Hall, Ute Hamann, Patricia A. Harrington, Steven N. Hart, Maartje J. Hooning, John L. Hopper, Anthony Howell, David J. Hunter, Agnes Jager, Anna Jakubowska, Esther M. John, Rudolf Kaaks, Renske Keeman, Elza Khusnutdinova, Cari M. Kitahara, Veli-Matti Kosma, Stella Koutros, Peter Kraft, Vessela N. Kristensen, Allison W. Kurian, Diether Lambrechts, Loic Le Marchand, Martha Linet, Jan Lubiński, Arto Mannermaa, Siranoush Manoukian, Sara Margolin, John W. M. Martens, Dimitrios Mavroudis, Rebecca Mayes, Alfons Meindl, Roger L. Milne, Susan L. Neuhausen, Heli Nevanlinna, William G. Newman, Sune F. Nielsen, Børge G. Nordestgaard, Nadia Obi, Andrew F. Olshan, Janet E. Olson, Håkan Olsson, Ester Orban, Tjoung-Won Park-Simon, Paolo Peterlongo, Dijana Plaseska-Karanfilska, Katri Pylkäs, Gad Rennert, Hedy S. Rennert, Kathryn J. Ruddy, Emmanouil Saloustros, Dale P. Sandler, Elinor J. Sawyer, Rita K. Schmutzler, Christopher Scott, Xiao-Ou Shu, Jacques Simard, Snezhana Smichkoska, Christof Sohn, Melissa C. Southey, John J. Spinelli, Jennifer Stone, Rulla M. Tamimi, Jack A. Taylor, Rob A. E. M. Tollenaar, Ian Tomlinson, Melissa A. Troester, Thérèse Truong, Celine M. Vachon, Elke M. van Veen, Sophia S. Wang, Clarice R. Weinberg, Camilla Wendt, Hans Wildiers, Robert Winqvist, Alicja Wolk, Wei Zheng, Argyrios Ziogas, Alison M. Dunning, Paul D. P. Pharoah, Douglas F. Easton, A. Forbes Howie, Julian Peto, Isabel dos-Santos-Silva, Anthony J. Swerdlow, Jenny Chang-Claude, Marjanka K. Schmidt, Nick Orr & Olivia Fletcher. (2021) CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer 124:4, pages 842-854.
Crossref
Crossref
Huifang Shi, Jianguang Xu, Qiong Feng, Juan Sun, Yixiu Yang, Jie Zhao, Xiaoli Zhou, Huan Niu, Ping He, Jianfang Liu, Quanni Li & Yipeng Ding. (2020) The effect of CYP3A4 genetic variants on the susceptibility to chronic obstructive pulmonary disease in the Hainan Han population. Genomics 112:6, pages 4399-4405.
Crossref
Crossref
Paolina Crocco, Alberto Montesanto, Serena Dato, Silvana Geracitano, Francesca Iannone, Giuseppe Passarino & Giuseppina Rose. (2019) Inter-Individual Variability in Xenobiotic-Metabolizing Enzymes: Implications for Human Aging and Longevity. Genes 10:5, pages 403.
Crossref
Crossref
P. Holy, A. Kloudova & P. Soucek. (2018) Importance of genetic background of oxysterol signaling in cancer. Biochimie 153, pages 109-138.
Crossref
Crossref
CHUNJIE MENG, ZHIYUN WEI, YITING ZHANG, LIANG YAN, HANG HE, LIRONG ZHANG & QINGHE XING. (2016) Regulation of cytochrome P450 3A4 by small vault RNAb derived from the non-coding vault RNA1 of multidrug resistance-linked vault particle. Molecular Medicine Reports 14:1, pages 387-393.
Crossref
Crossref
Olivia J. Creemer, Naser Ansari-Pour, Rosemary Ekong, Ayele Tarekegn, Christopher Plaster, Ripudaman K. Bains, Yuval Itan, Endashaw Bekele & Neil Bradman. (2016) Contrasting exome constancy and regulatory region variation in the gene encoding CYP3A4. Pharmacogenetics and Genomics 26:6, pages 255-270.
Crossref
Crossref
Nichola Johnson, Paolo De Ieso, Gabriele Migliorini, Nick Orr, Peter Broderick, Daniel Catovsky, Athena Matakidou, Timothy Eisen, Christy Goldsmith, Frank Dudbridge, Julian Peto, Isabel dos-Santos-Silva, Alan Ashworth, Gillian Ross, Richard S. Houlston & Olivia Fletcher. (2016)
Cytochrome P450 Allele
CYP3A7*1C
Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer
. Cancer Research 76:6, pages 1485-1493.
Crossref
Crossref
Y. Akamine, H. Uehara, M. Miura, N. Yasui-Furukori & T. Uno. (2015) Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine. Journal of Clinical Pharmacy and Therapeutics 40:4, pages 480-482.
Crossref
Crossref
Ann K. Daly. 2015. Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer. Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer
85
111
.
Kristen M Maynard, Upasana Arvindam, Madeline Cross & Meri T Firpo. (2014) Potentially immunogenic proteins expressed similarly in human embryonic stem cells and induced pluripotent stem cells. Experimental Biology and Medicine 239:4, pages 484-488.
Crossref
Crossref
Mariana R. Botton, Patrícia P. Viola, Eliane Bandinelli, Tiago L. L. Leiria, Luis E. P. Rohde & Mara H. Hutz. (2014) A New Algorithm for Weekly Phenprocoumon Dose Variation in a Southern Brazilian Population: Role for CYP2C9, CYP3A4/5 and VKORC1 Genes Polymorphisms. Basic & Clinical Pharmacology & Toxicology 114:4, pages 323-329.
Crossref
Crossref
C.S. Dalbøge, X.C. Nielsen, K. Dalhoff, J.W. Alffenaar, M. Duno, A. Buchard, D.R.A. Uges, A.G. Jensen, G. Jürgens, T. Pressler, H.K. Johansen & N. Høiby. (2014) Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis. Journal of Cystic Fibrosis 13:2, pages 179-185.
Crossref
Crossref
Hylke de Jonge, Henriette de Loor, Krisitin Verbeke, Yves Vanrenterghem & Dirk RJ Kuypers. (2013)
Impact of
CYP3A5
genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism
. Pharmacogenomics 14:12, pages 1467-1480.
Crossref
Crossref
Ibrahim Ince, Catherijne A. J. Knibbe, Meindert Danhof & Saskia N. de Wildt. (2013) Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations. Clinical Pharmacokinetics 52:5, pages 333-345.
Crossref
Crossref
Ulrich M. Zanger & Matthias Schwab. (2013) Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics 138:1, pages 103-141.
Crossref
Crossref
Robert M. Ward & Gregory L. Kearns. (2013) Proton Pump Inhibitors in Pediatrics. Pediatric Drugs 15:2, pages 119-131.
Crossref
Crossref
Ripudaman K Bains, Mirna Kovacevic, Christopher A Plaster, Ayele Tarekegn, Endashaw Bekele, Neil N Bradman & Mark G Thomas. (2013) Molecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa. BMC Genetics 14:1, pages 34.
Crossref
Crossref
Deidre A. KileSamantha MaWhinneyChristina L. AquilanteJoseph E. RowerJose R. Castillo-MancillaPeter L. Anderson. (2012) A Population Pharmacokinetic-Pharmacogenetic Analysis of Atazanavir. AIDS Research and Human Retroviruses 28:10, pages 1227-1234.
Crossref
Crossref
Kathrin Klein, Maria Thomas, Stefan Winter, Andreas K. Nussler, Mikko Niemi, Matthias Schwab & Ulrich M. Zanger. (2012) PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo. Clinical Pharmacology & Therapeutics 91:6, pages 1044-1052.
Crossref
Crossref
Nichola Johnson, Kate Walker, Lorna J. Gibson, Nick Orr, Elizabeth Folkerd, Ben Haynes, Claire Palles, Ben Coupland, Minouk Schoemaker, Michael Jones, Peter Broderick, Elinor Sawyer, Michael Kerin, Ian P. Tomlinson, Marketa Zvelebil, Sarah Chilcott-Burns, Katarzyna Tomczyk, Gemma Simpson, Jill Williamson, Stephen G. Hillier, Gillian Ross, Richard S. Houlston, Anthony Swerdlow, Alan Ashworth, Mitch Dowsett, Julian Peto, Isabel dos Santos Silva & Olivia Fletcher. (2012) CYP3A Variation, Premenopausal Estrone Levels, and Breast Cancer Risk. JNCI: Journal of the National Cancer Institute 104:9, pages 657-669.
Crossref
Crossref
Meghan Brennan, J. Andrew Williams, Ying Chen, Michael Tortorici, Yazdi Pithavala & Yingxue Cathy Liu. (2011) Meta-analysis of contribution of genetic polymorphisms in drug-metabolizing enzymes or transporters to axitinib pharmacokinetics. European Journal of Clinical Pharmacology 68:5, pages 645-655.
Crossref
Crossref
Ulrich M. Zanger, Kathrin Klein & Jessica Rieger. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
259
284
.
Alexander V. LyubimovLin Xu, Biplab Das & Chandra Prakash. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
35
.
Alexander V. LyubimovAnahita Bhathena & David A. Katz. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
27
.
Alexander V. LyubimovUlrich M. Zanger. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
36
.
Jakob Jornil, Klaus Gjervig Jensen, Frank Larsen & Kristian Linnet. (2011) Risk assessment of accidental nortriptyline poisoning: The importance of cytochrome P450 for nortriptyline elimination investigated using a population-based pharmacokinetic simulator. European Journal of Pharmaceutical Sciences 44:3, pages 265-272.
Crossref
Crossref
Qing Zhou, Xiaomin Yu, Chang Shu, Yimei Cai, Wei Gong, Xumin Wang, Duen-mei Wang & Songnian Hu. (2011) Analysis of CYP3A4 genetic polymorphisms in Han Chinese. Journal of Human Genetics 56:6, pages 415-422.
Crossref
Crossref
Cynthia A. Prows. (2011) Infusion of Pharmacogenetics Into Cancer Care. Seminars in Oncology Nursing 27:1, pages 45-53.
Crossref
Crossref
Henry P. Parkman, Michael R. Jacobs, Anurag Mishra, Jessica A. Hurdle, Priyanka Sachdeva, John P. Gaughan & Evgeny Krynetskiy. (2010) Domperidone Treatment for Gastroparesis: Demographic and Pharmacogenetic Characterization of Clinical Efficacy and Side-Effects. Digestive Diseases and Sciences 56:1, pages 115-124.
Crossref
Crossref
Sarah L Hulin-Curtis, Dominique Petit, W Douglas Figg, Ann W Hsing & Juergen KV Reichardt. (2010) Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer. Future Oncology 6:12, pages 1897-1913.
Crossref
Crossref
Dorota Tomalik-Scharte, Dominique Maiter, Julia Kirchheiner, Hannah E Ivison, Uwe Fuhr & Wiebke Arlt. (2010) Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. European Journal of Endocrinology 163:6, pages 919-924.
Crossref
Crossref
Ann K. Daly. (2010) Pharmacogenetics and human genetic polymorphisms. Biochemical Journal 429:3, pages 435-449.
Crossref
Crossref